Neil Woodford's High Income fund has returned his investors' seed money 22 times over in 25 years, far more than the index or an average of his rivals. Can his replacement duplicate this, or can Woodford do it elsewhere?
It's a very tall order. The sales pitch of active fund management is based on managers' skill, not chance. But managers who achieve what Woodford has done are statistically very rare.
It's impossible to know if such a record is down to luck or skill. Put another way, of the thousands of fund managers, a Woodford is bound to pop up sooner or later. But can you pick him?
Try 6 free issues of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Start your trial
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
So, all you can be sure of if you buy Woodford's (or his replacement's) income funds is costs: 1.67% in charges for the Invesco Perpetual High Income Fund, plus another 0.14% a year in commissions and taxes generated by the manager's turnover.
Latest Videos FromMoneyWeek
The Edinburgh Investment Trust (LSE: EDIN), also run by Woodford, levied 1.9% in fees last year (0.7% in charges, plus 1.2% as a performance fee), plus 0.1% in turnover-related costs.
Either way, you're getting on for 2% in charges per year for either fund (and that's assuming you found someone to waive the initial charge of 5% on the High Income Fund).
Investors in his trust have also just seen a near-10% swing in its secondary market price as the fund swung from a premium to a discount to net asset value (in other words, the shares went from trading above the price of the underlying portfolio to below it) after Woodford's decision to leave Invesco was announced.
If instead, you buy an exchange-traded fund (ETF), or index fund tracking a high-income index, you'll end up holding many of the pharmaceutical and tobacco stocks that Woodford's active funds still hold.
These index funds tend to hold less concentrated portfolios than Woodford, who takes big bets. Nor should they swing to premia or discounts. More importantly, they're far cheaper: Vanguard's UK Equity Index Fund costs 0.25% a year, SDPR Europe's UK Dividend Aristocrats ETF (LSE: UKDV) charges 0.3% and iShares' UK Dividend ETF (LSE: IUKD) costs 0.4% a year. Trading costs add a few basis points a year on top, but they are nowhere near the price of an average active fund.
Personally, I'm not a fan of income stocks right now I think the flood of quantitative-easing-inspired hot money has left them overvalued. But if I were buying an income fund, I'd definitely prefer an ETF or index fund over an active fund that costs up to eight times more.
Paul Amery, formerly a fund manager and trader, is now a freelance journalist.
